黑色素瘤转移的临床试验
总计12017个结果
-
Threshold Pharmaceuticals终止
-
University of Texas Southwestern Medical Center撤销
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)完全的
-
The Netherlands Cancer InstituteMerck Sharp & Dohme LLC未知
-
Altor BioScienceNational Cancer Institute (NCI)完全的
-
SCRI Development Innovations, LLCNovartis完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)完全的
-
Cooperative Research Centre for Biomedical Imaging...未知
-
National Cancer Institute (NCI)完全的
-
Centre Hospitalier Universitaire Vaudois主动,不招人
-
Dana-Farber Cancer InstituteAstraZeneca撤销
-
Pierre Fabre Medicament招聘中
-
Centre Hospitalier Universitaire de Nice招聘中
-
Centre Hospitalier Universitaire Vaudois主动,不招人
-
Providence Health & ServicesPrometheus Laboratories主动,不招人
-
H. Lee Moffitt Cancer Center and Research Institute主动,不招人
-
The Netherlands Cancer InstituteCopenhagen University Hospital at Herlev主动,不招人
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.主动,不招人
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLC终止
-
Iovance Biotherapeutics, Inc.主动,不招人
-
Novartis Pharmaceuticals终止
-
F. Stephen Hodi, MDMedImmune LLC完全的
-
The Christie NHS Foundation TrustNational Institute for Health Research, United Kingdom终止
-
Biocad主动,不招人黑色素瘤 | 黑色素瘤转移俄罗斯联邦, 白俄罗斯
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer Institute终止
-
Nektar TherapeuticsImaginAb, Inc.撤销
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer Institute撤销
-
BioNTech US Inc.Apexigen, Inc.终止
-
Nantes University HospitalUMR892完全的
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics Inc.完全的